Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Status:
Completed
Trial end date:
2014-03-17
Target enrollment:
Participant gender:
Summary
RATIONALE:
1. . To compare the effects on breast cancer of three different combinations of drugs which
are commonly used to treat this disease.
2. . It is not yet known which treatment regimen is most effective for breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
given with or without epoetin alfa in treating women who have undergone surgery for stage I,
stage II, or stage III breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
NCIC Clinical Trials Group
Collaborators:
Cancer and Leukemia Group B North Central Cancer Treatment Group Southwest Oncology Group